Cargando…

The 10 Commandments for Transapical TAVI

Detalles Bibliográficos
Autores principales:	Dahle, Gry, Walther, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Focused Topic Series: Alternative TAVR Access
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315863/ https://www.ncbi.nlm.nih.gov/pubmed/37309902 http://dx.doi.org/10.1177/15569845231177052

Ejemplares similares

Massive TAVR: Complex Transcatheter Aortic Valve Replacement in the Setting of an Enormous Adnexal Mass
por: Chauhan, Siddharth, et al.
Publicado: (2020)

Transcatheter Aortic Valve Replacement of a Bicuspid Aortic Valve in a Heart Transplant Recipient
por: Beale, Robert, et al.
Publicado: (2020)

The 10 Commandments of Open Aortic Arch Repair
por: Werner, Paul, et al.
Publicado: (2022)

Quantitation of Tacrolimus in Human Whole Blood Samples Using the MITRA Microsampling Device
por: Undre, Nasrullah, et al.
Publicado: (2021)

Validation of a Capillary Dry Blood Sample MITRA-Based Assay for the Quantitative Determination of Systemic Tacrolimus Concentrations in Transplant Recipients
por: Undre, Nasrullah, et al.
Publicado: (2021)

Tacrolimus Measured in Capillary Volumetric Microsamples in Pediatric Patients—A Cross-Validation Study
por: Kindem, Ingvild Andrea, et al.
Publicado: (2021)

Patient Detection of a Drug Dispensing Error by Use of Physician-Provided Drug Samples
por: Ashley, Elizabeth S Dodds, et al.
Publicado: (2002)

Science or Fiction: Use of Nesiritide as a First-Line Agent?
por: Noviasky, John A, et al.
Publicado: (2003)

Assessing the risk of stroke from neck manipulation: a systematic review
por: Haynes, M J, et al.
Publicado: (2012)

Assessment of food habits in children aged 6–12 years and the risk of caries
por: Doichinova, Liliya, et al.
Publicado: (2015)

Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies
por: Law, Arjun Datt, et al.
Publicado: (2018)

An analysis of real-world cost-effectiveness of TAVI in South Africa
por: Mabin, Thomas A, et al.
Publicado: (2014)

Introduction
por: Fava, Maria
Publicado: (2023)

The state of web accessibility at CERN today
por: Noble, Catharine
Publicado: (2023)

Future Plans
por: Yde, Joachim Valdemar
Publicado: (2023)

Concepts and Resources
por: Noble, Catharine
Publicado: (2023)

Exercises and corresponding examples from CERNBox
por: Tamarit, Pablo, et al.
Publicado: (2023)

Accession of Poland
Publicado: (1990)

Status Report on the Accession of Hungary
Publicado: (1991)

Accession of the Czech and Slovak Federal Republic
Publicado: (1991)

Accession of the Czech and Slovak Federal Republic
Publicado: (1991)

Status Report on the Accession of Czechoslovakia
Publicado: (1991)

Accession of the Republic of Hungary
Publicado: (1992)

Accession of the Czech and Slovak Federal Republic
Publicado: (1991)

Accession of the Czech Republic to CERN
Publicado: (1993)

Addendum to document CERN/CC/1968 - Accession of the Czech Republic to CERN - "Particle Physics in the Czech Republic"
Publicado: (1993)

Accession of the Slovak Republic
Publicado: (1993)

Addendum to document CERN/CC/1969 - Accession of the Slovak Republic to CERN - "Particle Physics in the Slovak Republic"
Publicado: (1993)

Accession of the Czech Republic
Publicado: (1993)

Accession of the Slovak Republic
Publicado: (1993)

Accession of Portugal
Publicado: (1985)

Accession of Portugal
Publicado: (1985)

Accession of Portugal
Publicado: (1985)

Accession of Spain
Publicado: (1982)

Accession of Spain
Publicado: (1982)

Accession of Finland
Publicado: (1990)

Future Relationship Between Yugoslavia and CERN
Publicado: (1961)

Position of Yugoslavia
Publicado: (1962)

Recommendation to Council on the Accession of Spain
Publicado: (1960)

Recommendation to Council on the Accession of Spain
Publicado: (1960)

Cannot write session to /tmp/vufind_sessions/sess_u80tqa2msoagd30eefbhg91e5o